Monoclonal antibodies (mAbs) targeting the spike protein of SARS-CoV-2 have been widely
used in the ongoing COVID-19 pandemic. In this paper, we review the properties of mAbs …

Abstract WHO-defined SARS-CoV-2 variants of concern (VOC) drive therapeutics and
vaccine development. The Omicron VOC is dominating the arena since November 2021, but …

Since the origin of the wild strain of SARS-CoV-2, several variants have emerged, which
were designated as VOC, VOI, and VUM from time to time. The Omicron variant is noted as …

Background The pandemic of coronavirus disease 2019 (COVID‐19) has a broad spectrum
of clinical manifestations. The severe acute respiratory syndrome coronavirus‐2 (SARS …

Monitoring of SARS-CoV-2 in wastewater (WW) is a promising tool for epidemiological
surveillance, correlating not only viral RNA levels with the infection dynamics within the …

New sublineages of SARS-CoV-2 variants-of-concern (VOCs) continuously emerge with
mutations in the spike glycoprotein. In most cases, the sublineage-defining mutations vary …

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in
December 2019 resulted in the coronavirus disease 2019 (COVID-19) pandemic, which has …

Introduction The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic
has been fueled by new variants emerging from circulating strains. Here, we report results …

Since the beginning of the pandemic, SARS‐CoV‐2 has shown a great genomic variability,
resulting in the continuous emergence of new variants that has made their global monitoring …

Vaccination is a key control measure of COVID-19 by preventing severe effects of disease
outcomes, reducing hospitalization rates and death, and increasing herd immunity …